Bikaramjit Mann, MD

Articles by Bikaramjit Mann, MD

A Systematic Review of Value-Based Insurance Design in Chronic Diseases

ByKaren L. Tang, MD,Lianne Barnieh, PhD,Bikaramjit Mann, MD,Fiona Clement, PhD,David J.T. Campbell, MD, MSc,Brenda R. Hemmelgarn, MD, PhD,Marcello Tonelli, MD, SM,Diane Lorenzetti, MLS,Braden J. Manns, MD, MSc

October 14th 2014

Value-based insurance design for prescription drug coverage increases drug adherence in patients with chronic disease, though their effect on clinical outcomes and health spending remain uncertain.

Latest Updated Articles

A Systematic Review of Value-Based Insurance Design in Chronic Diseases
Published: October 14th 2014 | Updated:

Bikaramjit Mann, MD

Articles by Bikaramjit Mann, MD

A Systematic Review of Value-Based Insurance Design in Chronic Diseases

Latest Updated Articles

Trending on AJMC

Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies

Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear

CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts

Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD

Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP